Fifteen novel EIF2B1-5 mutations identified in Chinese children with leukoencephalopathy with vanishing white matter and a long term follow-up

PloS One
Haihua ZhangYe Wu

Abstract

Leukoencephalopathy with vanishing white matter (VWM) is one of the most prevalent inherited childhood white matter disorders, which caused by mutations in each of the five subunits of eukaryotic translation initiation factor 2B (EIF2B1-5). In our study, 34 out of the 36 clinically diagnosed children (94%) were identified to have EIF2B1-5 mutations by sequencing. 15 novel mutations were identified. CNVs were not detected in patients with only one mutant allele and mutation-negative determined by gene sequencing. There is a significantly higher incidence of patients with EIF2B3 mutations compared with Caucasian patients (32% vs. 4%). c.1037T>C (p.Ile346Thr) in EIF2B3 was confirmed to be a founder mutation in Chinese, which probably one of the causes of the genotypic differences between ethnicities. Our average 4.4 years-follow-up on infantile, early childhood and juvenile VWM children suggested a rapid deterioration in motor function. Episodic aggravation was presented in 90% of infantile cases and 71.4% of childhood cases. 10 patients died during the follow-up. The Kaplan-Meier curve showed that the median survival time is 8.83 ± 1.51 years. This is the largest sample of children in a VWM follow-up study, which is helpful for a...Continue Reading

References

Mar 1, 1994·Annals of Neurology·R SchiffmannC R Kaneski
Apr 1, 1997·Neurology·M S van der KnaapJ Valk
Aug 26, 1998·Neurology·M S van der KnaapJ Valk
Apr 23, 2003·American Journal of Human Genetics·Anne FogliOdile Boespflug-Tanguy
Oct 21, 2003·American Journal of Human Genetics·Marjo S van der KnaapJan C Pronk
Apr 1, 2004·European Journal of Human Genetics : EJHG·Anne FogliOdile Boespflug-Tanguy
Mar 19, 2005·Human Mutation·Andreas OhlenbuschJutta Gärtner
Sep 28, 2005·Neurobiology of Disease·Barbara van KollenburgGert C Scheper
Oct 4, 2005·Scientific American·Dennis Drayna
Apr 25, 2006·Lancet Neurology·Marjo S van der KnaapGert C Scheper
Jun 30, 2006·Mental Retardation and Developmental Disabilities Research Reviews·Jan C PronkMarjo S van der Knaap
Sep 26, 2006·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·O ScaliA Federico
Feb 12, 2008·Journal of Child Neurology·Jelena MaletkovicAdeline Vanderver
Jul 25, 2009·Brain : a Journal of Neurology·Pierre LabaugeOdile Boespflug-Tanguy
May 7, 2010·The Journal of Biological Chemistry·Jon R Lorsch, Thomas E Dever
Sep 15, 2010·Journal of Neuropathology and Experimental Neurology·Marianna BugianiMarjo S van der Knaap
Oct 27, 2010·Neurology·H D W van der LeiM S van der Knaap
Sep 3, 2011·Microbiology and Molecular Biology Reviews : MMBR·Alan G Hinnebusch
Jun 9, 2012·American Journal of Medical Genetics. Part a·Shino ShimadaToshiyuki Yamamoto
Jul 9, 2013·Cancer Letters·Rita SpilkaJohannes Haybaeck

❮ Previous
Next ❯

Citations

Jan 4, 2017·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Jin Sook LeeJong-Hee Chae
Aug 7, 2019·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Gülay GüngörKürşad Aydın
Sep 1, 2021·Wiley Interdisciplinary Reviews. RNA·Alyssa M EnglishStephanie L Moon

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
exome sequencing

Software Mentioned

Mutation Taster
SIFT
SPSS16
PolyPhen2

Related Concepts

Related Feeds

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on different types of ataxias here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.